216 related articles for article (PubMed ID: 16789014)
1. Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART.
Schüpbach J; Tomasik Z; Knuchel M; Opravil M; Günthard HF; Nadal D; Böni J; ;
J Med Virol; 2006 Aug; 78(8):1003-10. PubMed ID: 16789014
[TBL] [Abstract][Full Text] [Related]
2. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
Schüpbach J
AIDS Rev; 2002; 4(2):83-92. PubMed ID: 12152521
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection.
Nadal D; Böni J; Kind C; Varnier OE; Steiner F; Tomasik Z; Schüpbach J
J Infect Dis; 1999 Oct; 180(4):1089-95. PubMed ID: 10479135
[TBL] [Abstract][Full Text] [Related]
4. Quantification of HIV-1 p24 by a highly improved ELISA: an alternative to HIV-1 RNA based treatment monitoring in patients from Abidjan, Côte d'Ivoire.
Tehe A; Maurice C; Hanson DL; Borget MY; Abiola N; Maran M; Yavo D; Tomasik Z; Böni J; Schüpbach J; Nkengasong JN
J Clin Virol; 2006 Nov; 37(3):199-205. PubMed ID: 16973409
[TBL] [Abstract][Full Text] [Related]
5. Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction.
Schüpbach J; Flepp M; Pontelli D; Tomasik Z; Lüthy R; Böni J
AIDS; 1996 Sep; 10(10):1085-90. PubMed ID: 8874624
[TBL] [Abstract][Full Text] [Related]
6. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa.
Stevens G; Rekhviashvili N; Scott LE; Gonin R; Stevens W
J Clin Microbiol; 2005 Feb; 43(2):857-61. PubMed ID: 15695692
[TBL] [Abstract][Full Text] [Related]
8. [Non conventional virological markers in HIV-infected patients: T-HIV DNA, 2LTR-HIV DNA and HIV RNA].
Gariglio R; Taborda MA; Bortolozzi R; McDermott JL; Martini I; Borgognone M; Villanova GV; Varnier OE; Giri AA
Medicina (B Aires); 2004; 64(5):419-28. PubMed ID: 15560543
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement.
Ledergerber B; Flepp M; Böni J; Tomasik Z; Cone RW; Lüthy R; Schüpbach J
J Infect Dis; 2000 Apr; 181(4):1280-8. PubMed ID: 10751136
[TBL] [Abstract][Full Text] [Related]
10. Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma.
Böni J; Opravil M; Tomasik Z; Rothen M; Bisset L; Grob PJ; Lüthy R; Schüpbach J
AIDS; 1997 May; 11(6):F47-52. PubMed ID: 9143600
[TBL] [Abstract][Full Text] [Related]
11. Ultrasensitive quantitative HIV-1 p24 antigen assay adapted to dried plasma spots to improve treatment monitoring in low-resource settings.
Knuchel MC; Tomasik Z; Speck RF; Lüthy R; Schüpbach J
J Clin Virol; 2006 May; 36(1):64-7. PubMed ID: 16431154
[TBL] [Abstract][Full Text] [Related]
12. The measurement of HIV-1 viral load in resource-limited settings: how and where?
Rouet F; Rouzioux C
Clin Lab; 2007; 53(3-4):135-48. PubMed ID: 17447649
[TBL] [Abstract][Full Text] [Related]
13. Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation.
Bonora S; Nicastri E; Calcagno A; Gonzalez de Requena D; D'Ettorre G; Sarmati L; Palmisano L; Vullo V; Di Perri G; Andreoni M
J Med Virol; 2009 Mar; 81(3):400-5. PubMed ID: 19152404
[TBL] [Abstract][Full Text] [Related]
14. Lowering the detection limits of HIV-1 viral load using real-time immuno-PCR for HIV-1 p24 antigen.
Barletta JM; Edelman DC; Constantine NT
Am J Clin Pathol; 2004 Jul; 122(1):20-7. PubMed ID: 15272526
[TBL] [Abstract][Full Text] [Related]
15. Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia.
Sabin CA; Lepri AC; Devereux H; Phillips AN; Loveday C; Lee CA
J Infect Dis; 2001 Aug; 184(4):511-4. PubMed ID: 11471111
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
Bisson GP; Gross R; Strom JB; Rollins C; Bellamy S; Weinstein R; Friedman H; Dickinson D; Frank I; Strom BL; Gaolathe T; Ndwapi N
AIDS; 2006 Aug; 20(12):1613-9. PubMed ID: 16868442
[TBL] [Abstract][Full Text] [Related]
17. Virological characterization of patients treated early is able to control HIV-1 replication after multiple cycles of structured therapy interruption.
Rozera G; Abbate I; D'Offizi G; Corpolongo A; Narciso P; Vlassi C; Martini F; Calcaterra S; Capobianchi MR
J Med Virol; 2007 Aug; 79(8):1047-54. PubMed ID: 17597482
[TBL] [Abstract][Full Text] [Related]
18. Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization.
Kran AM; Sommerfelt MA; Sørensen B; Nyhus J; Baksaas I; Bruun JN; Kvale D
Vaccine; 2005 Jul; 23(31):4011-5. PubMed ID: 15963359
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of highly active antiretroviral therapy in HIV-1 infected children in Kenya.
Song R; Jelagat J; Dzombo D; Mwalimu M; Mandaliya K; Shikely K; Essajee S
Pediatrics; 2007 Oct; 120(4):e856-61. PubMed ID: 17846147
[TBL] [Abstract][Full Text] [Related]
20. Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease.
Sterling TR; Hoover DR; Astemborski J; Vlahov D; Bartlett JG; Schupbach J
J Infect Dis; 2002 Oct; 186(8):1181-5. PubMed ID: 12355373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
